On July 14, 2009 the Office of Life Sciences of the British Government announced its Blueprint intended to promote life science companies and ensure faster patient access to innovative therapies. Key initiatives described in the blueprint include:
- The Innovation Pass - a three year initiative that will allow selected innovative drugs to be available through the National Health Service (NHS) without being subject to a National Institute for Heath and Clinical Excellence (NICE) appraisal. NICE will have a key role in selecting the therapies eligible for the Innovation Pass.
- Review of Incentives - NHS will review incentives to encourage the uptake of new medical technologies.
- Accreditation - the Society of Biology will accredit undergraduate bioscience degrees to ensure graduates have the level of skill and competency required by employers.
For more information or to download a copy of the Blueprint, please see the Office for Life Sciences' web-site at http://www.dius.gov.uk/ols.